Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Pioneer heart surgeon dies at 92 | AI-based soft plaque assessments | A new approach for valve-in-valve TMVR
Friday, July 22, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Pioneer heart surgeon and philanthropist Allan Lansing dies at 92

Allan Lansing, MD, PhD, performed the first coronary artery bypass in the state of Kentucky. He also volunteered to help patients all over the world and was publicly honored by President George H. W. Bush in 1991. 

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Pioneer heart surgeon and philanthropist Allan Lansing dies at 92

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
Allan Lansing, MD, PhD, performed the first coronary artery bypass in the state of Kentucky. He also volunteered to help patients all over the world and was publicly honored by President George H. W. Bush in 1991. 
READ MORE >

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting. 

READ MORE >
Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

Share on Twitter Share on Facebook Share on Linkedin
Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.
New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting. 
READ MORE >

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.

READ MORE >
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

Share on Twitter Share on Facebook Share on Linkedin
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.
READ MORE >

An immediate impact: Smartphone app boosts health of Black patients in just 10 weeks

A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.

READ MORE >
LaPrincess Brewer, M.D., a Mayo Clinic preventive cardiologist and principal investigator of the study, explains a heart model.
Share on Twitter Share on Facebook Share on Linkedin

An immediate impact: Smartphone app boosts health of Black patients in just 10 weeks

Share on Twitter Share on Facebook Share on Linkedin
LaPrincess Brewer, M.D., a Mayo Clinic preventive cardiologist and principal investigator of the study, explains a heart model.
A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.
READ MORE >

Featured Articles

VIDEO: Top 6 takeaways from the Society of Cardiovascular CT 2022 meeting

Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference. 

READ MORE >
Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shares his key takeaways from the SCCT 2022 conference. #SCCT #SCCT2022 #yesCCT
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Top 6 takeaways from the Society of Cardiovascular CT 2022 meeting

Share on Twitter Share on Facebook Share on Linkedin
Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shares his key takeaways from the SCCT 2022 conference. #SCCT #SCCT2022 #yesCCT
Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference. 
READ MORE >

Subclinical leaflet thrombosis after TAVR: What we know, and still need to learn, about a challenging complication

Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic. 

READ MORE >
Subclinical leaflet thrombosis after TAVR imaged by CT. The areas of clot attached to the valve leaflets appear dark. Image courtesy of Cahill et al. and JAMA Cardiology.
Share on Twitter Share on Facebook Share on Linkedin

Subclinical leaflet thrombosis after TAVR: What we know, and still need to learn, about a challenging complication

Share on Twitter Share on Facebook Share on Linkedin
Subclinical leaflet thrombosis after TAVR imaged by CT. The areas of clot attached to the valve leaflets appear dark. Image courtesy of Cahill et al. and JAMA Cardiology.
Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic. 
READ MORE >

In Other News

Amazon to acquire One Medical for $3.9B

Amazon is taking another big step into the healthcare space, announcing its plans to acquire technology-forward primary care organization One Medical for a whopping $3.9 billion.

READ MORE >
Amazon is acquiring One Medical in a $3.9 billion deal
Share on Twitter Share on Facebook Share on Linkedin

Amazon to acquire One Medical for $3.9B

Share on Twitter Share on Facebook Share on Linkedin
Amazon is acquiring One Medical in a $3.9 billion deal
Amazon is taking another big step into the healthcare space, announcing its plans to acquire technology-forward primary care organization One Medical for a whopping $3.9 billion.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme